Edition:
United States

Novavax Inc (NVAX.OQ)

NVAX.OQ on NASDAQ Stock Exchange Global Select Market

7.32USD
29 Jul 2016
Change (% chg)

$-0.06 (-0.81%)
Prev Close
$7.38
Open
$7.32
Day's High
$7.43
Day's Low
$7.11
Volume
709,764
Avg. Vol
1,170,151
52-wk High
$15.00
52-wk Low
$4.08

NVAX.OQ

Chart for NVAX.OQ

About

Novavax, Inc. (Novavax) is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through developing recombinant vaccines segment. The Company through its recombinant nanoparticle vaccine technology produces vaccine... (more)

Overall

Beta: 1.36
Market Cap(Mil.): $1,998.38
Shares Outstanding(Mil.): 270.78
Dividend: --
Yield (%): --

Financials

  NVAX.OQ Industry Sector
P/E (TTM): -- 41.55 39.69
EPS (TTM): -0.78 -- --
ROI: -45.05 -9.57 14.44
ROE: -71.72 -9.91 15.49

BRIEF-FDA grants fast track designation to Novavax' RSV F vaccine

* U.S. FDA grants fast track designation to Novavax' RSV F vaccine for older adults Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

May 25 2016

BRIEF-Novavax Inc Q1 loss per share $0.29

* Q1 earnings per share view $-0.27 -- Thomson Reuters I/B/E/S

May 04 2016

BRIEF-Novavax reports Q1 loss per share of $0.29

* Q1 earnings per share view $-0.27 -- Thomson Reuters I/B/E/S

May 04 2016

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF80.30 0.00
Merck & Co., Inc. (MRK.N) $58.66 +0.23
Sanofi SA (SASY.PA) €76.15 -0.14
GlaxoSmithKline plc (GSK.L) 1,688.00p -11.50
AstraZeneca plc (AZN.L) 5,048.00p +21.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.